/BWV
BWV Stock - Blue Water Vaccines, Inc.
Healthcare|BiotechnologyNASDAQ
$0.18-6.97%
$0.01 (-6.97%) • Dec 21
61
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.80
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+2119.8%upside
Target: $4.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BWV
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.18 – $0.18
TARGET (TP)$4.00
STOP LOSS$0.17
RISK/REWARD1:374.5
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.00
52W High$1.95
52W Low$0.16
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $2.52M | N/A | N/A | N/A | N/A |
| Gross Profit | $1.06M | N/A | N/A | N/A | N/A |
| Gross Margin | 41.8% | N/A | N/A | N/A | N/A |
| Operating Income | $-56,488,755 | $-13,481,240 | $-3,417,334 | $-1,622,069 | $-880,232 |
| Net Income | $-58,691,023 | $-13,290,258 | $-3,417,334 | $-1,576,863 | $-763,598 |
| Net Margin | -2325.2% | N/A | N/A | N/A | N/A |
| EPS | $-21.45 | $-1.08 | $-0.31 | $-0.14 | $-0.07 |
Company Overview
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BWVBeat Rate
40%
Last 5 quarters
Avg Surprise
-40.2%
EPS vs Estimate
Beats / Misses
2/3
Last 12 quarters
Latest EPS
$-0.28
Q4 2023
EPS Surprise History
Q4 21
No data
Q2 22
No data
Q3 22
No data
Q4 22
-3.8%
$-0.27vs$-0.26
Q1 23
+36.0%
$-0.16vs$-0.25
Q2 23
+14.3%
$-0.18vs$-0.21
Q4 23
-200.0%
$-0.36vs$-0.12
Q4 23
-47.4%
$-0.28vs$-0.19
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | May 12, 2024 | — | — | — | — |
Q1 2024 | Mar 14, 2024 | $-0.11 | — | — | — |
Q4 2023 | Nov 17, 2023 | $-0.19 | $-0.28 | -47.4% | ✗ MISS |
Q4 2023 | Oct 2, 2023 | $-0.12 | $-0.36 | -200.0% | ✗ MISS |
Q2 2023 | May 12, 2023 | $-0.21 | $-0.18 | +14.3% | ✓ BEAT |
Q1 2023 | Mar 9, 2023 | $-0.25 | $-0.16 | +36.0% | ✓ BEAT |
Q4 2022 | Nov 10, 2022 | $-0.26 | $-0.27 | -3.8% | ✗ MISS |
Q3 2022 | Aug 15, 2022 | — | $-0.36 | — | — |
Q2 2022 | May 13, 2022 | — | $-0.33 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.11 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.10 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.07 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.03 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.04 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BWV
What is BWV's current stock price?
Blue Water Vaccines, Inc. (BWV) is currently trading at $0.18 per share. The stock has moved -6.97% today.
What is the analyst price target for BWV?
The average analyst price target for BWV is $4.00, based on 1 analyst.
What sector is Blue Water Vaccines, Inc. in?
Blue Water Vaccines, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is BWV's market cap?
Blue Water Vaccines, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does BWV pay dividends?
No, Blue Water Vaccines, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAFMD
Affimed N.V.
$0.18
Mkt Cap: $0.0B
AZRX
AzurRx BioPharma, Inc.
$3.45
Mkt Cap: $0.0B
BCEL
Atreca, Inc.
$0.09
Mkt Cap: $0.0B
GRTS
Gritstone bio, Inc.
$0.03
Mkt Cap: $0.0B
IDRA
Idera Pharmaceuticals, Inc.
$0.42
0LSTA
Lisata Therapeutics, Inc.
$2.06
Mkt Cap: $0.0B
QTTB
Q32 Bio Inc.
$2.96
Mkt Cap: $0.0B
RVLP
RVL Pharmaceuticals plc
$0.03
Mkt Cap: $0.0B
UBX
Unity Biotechnology, Inc.
$0.20
Mkt Cap: $0.0B
VIVS
VivoSim Labs, Inc.
$1.98
Mkt Cap: $0.0B
Explore stocks similar to BWV for comparison